A key first step for R&D and business development teams is screening diseases to pursue for discovery or in-licensing. Discovery Scan is designed to cost-effectively review and evaluate candidate diseases.

Equinox Group’s Discovery Scan tools:

• Provide a validated, consistent framework to measure medical need and compare diseases—in contrast to subjective techniques

• Characterize the nature of medical need in detail to generate insights about which attributes represent plausible targets for improvement

• Provide epidemiology for each disease to allow comparison of the size of patient populations

• Offer faster turn-around at less expense than traditional market research techniques

Discovery Scan allows teams to compare unmet need and its key components—disease seriousness, disease cost, and product need—across diseases.

Discovery Scan also provides information about the relative opportunities for reducing disease seriousness (mortality and morbidity) and for improving product attributes (efficacy, safety/tolerability, and dosing).

Key Targets for Improvement, by Disease